Regulation of signal transduction by HDL

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

High density lipoprotein (HDL) cholesterol has direct effects on numerous cell types that influence cardiovascular and metabolic health. These include endothelial cells, vascular smooth-muscle cells, leukocytes, platelets, adipocytes, skeletal muscle myocytes, and pancreatic β cells. The effects of HDL or apoA-I, its major apolipoprotein, occur through the modulation of intracellular calcium, oxygen-derived free-radical production, numerous kinases, and enzymes, including endothelial nitric-oxide synthase (eNOS). ApoA-I and HDL also influence gene expression, particularly genes encoding mediators of inflammation in vascular cells. In many paradigms, the change in intracellular signaling occurs as a result of cholesterol efflux, with the cholesterol acceptor methyl- β -cyclodextrin often invoking responses identical to HDL or apoA-I. The ABC transporters ABCA1 and ABCG1 and scavenger receptor class B, type I (SR-BI) frequently participate in the cellular responses. Structure-function relationships are emerging for signal initiation by ABCA1 and SR-BI, with plasma membrane cholesterol binding by the C-terminal transmembrane domain of SR-BI uniquely enabling it to serve as a sensor of changes in membrane cholesterol. Further investigation of the processes underlying HDL and apoA-I modulation of intracellular signaling will potentially reveal new prophylactic and therapeutic strategies to optimize both cardiovascular and metabolic health.

Original languageEnglish (US)
Pages (from-to)2315-2324
Number of pages10
JournalJournal of Lipid Research
Volume54
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Signal transduction
Apolipoprotein A-I
CD36 Antigens
HDL Lipoproteins
Signal Transduction
Cholesterol
Muscle
Modulation
Health
Inflammation Mediators
Gene encoding
ATP-Binding Cassette Transporters
Apolipoproteins
Nitric Oxide Synthase Type III
Skeletal Muscle Fibers
Endothelial cells
Cyclodextrins
Cell membranes
Platelets
Vascular Smooth Muscle

Keywords

  • Adenosine triphosphate-binding cassette (ABC) transporter A1 and G1
  • Apolipoprotein A-I, PDZK1
  • High density lipoprotein
  • Scavenger receptor class B, type I

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology

Cite this

Regulation of signal transduction by HDL. / Mineo, Chieko; Shaul, Philip W.

In: Journal of Lipid Research, Vol. 54, No. 9, 09.2013, p. 2315-2324.

Research output: Contribution to journalArticle

@article{549d380fa91c4e2c86de8977046ba56b,
title = "Regulation of signal transduction by HDL",
abstract = "High density lipoprotein (HDL) cholesterol has direct effects on numerous cell types that influence cardiovascular and metabolic health. These include endothelial cells, vascular smooth-muscle cells, leukocytes, platelets, adipocytes, skeletal muscle myocytes, and pancreatic β cells. The effects of HDL or apoA-I, its major apolipoprotein, occur through the modulation of intracellular calcium, oxygen-derived free-radical production, numerous kinases, and enzymes, including endothelial nitric-oxide synthase (eNOS). ApoA-I and HDL also influence gene expression, particularly genes encoding mediators of inflammation in vascular cells. In many paradigms, the change in intracellular signaling occurs as a result of cholesterol efflux, with the cholesterol acceptor methyl- β -cyclodextrin often invoking responses identical to HDL or apoA-I. The ABC transporters ABCA1 and ABCG1 and scavenger receptor class B, type I (SR-BI) frequently participate in the cellular responses. Structure-function relationships are emerging for signal initiation by ABCA1 and SR-BI, with plasma membrane cholesterol binding by the C-terminal transmembrane domain of SR-BI uniquely enabling it to serve as a sensor of changes in membrane cholesterol. Further investigation of the processes underlying HDL and apoA-I modulation of intracellular signaling will potentially reveal new prophylactic and therapeutic strategies to optimize both cardiovascular and metabolic health.",
keywords = "Adenosine triphosphate-binding cassette (ABC) transporter A1 and G1, Apolipoprotein A-I, PDZK1, High density lipoprotein, Scavenger receptor class B, type I",
author = "Chieko Mineo and Shaul, {Philip W.}",
year = "2013",
month = "9",
doi = "10.1194/jlr.R039479",
language = "English (US)",
volume = "54",
pages = "2315--2324",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "9",

}

TY - JOUR

T1 - Regulation of signal transduction by HDL

AU - Mineo, Chieko

AU - Shaul, Philip W.

PY - 2013/9

Y1 - 2013/9

N2 - High density lipoprotein (HDL) cholesterol has direct effects on numerous cell types that influence cardiovascular and metabolic health. These include endothelial cells, vascular smooth-muscle cells, leukocytes, platelets, adipocytes, skeletal muscle myocytes, and pancreatic β cells. The effects of HDL or apoA-I, its major apolipoprotein, occur through the modulation of intracellular calcium, oxygen-derived free-radical production, numerous kinases, and enzymes, including endothelial nitric-oxide synthase (eNOS). ApoA-I and HDL also influence gene expression, particularly genes encoding mediators of inflammation in vascular cells. In many paradigms, the change in intracellular signaling occurs as a result of cholesterol efflux, with the cholesterol acceptor methyl- β -cyclodextrin often invoking responses identical to HDL or apoA-I. The ABC transporters ABCA1 and ABCG1 and scavenger receptor class B, type I (SR-BI) frequently participate in the cellular responses. Structure-function relationships are emerging for signal initiation by ABCA1 and SR-BI, with plasma membrane cholesterol binding by the C-terminal transmembrane domain of SR-BI uniquely enabling it to serve as a sensor of changes in membrane cholesterol. Further investigation of the processes underlying HDL and apoA-I modulation of intracellular signaling will potentially reveal new prophylactic and therapeutic strategies to optimize both cardiovascular and metabolic health.

AB - High density lipoprotein (HDL) cholesterol has direct effects on numerous cell types that influence cardiovascular and metabolic health. These include endothelial cells, vascular smooth-muscle cells, leukocytes, platelets, adipocytes, skeletal muscle myocytes, and pancreatic β cells. The effects of HDL or apoA-I, its major apolipoprotein, occur through the modulation of intracellular calcium, oxygen-derived free-radical production, numerous kinases, and enzymes, including endothelial nitric-oxide synthase (eNOS). ApoA-I and HDL also influence gene expression, particularly genes encoding mediators of inflammation in vascular cells. In many paradigms, the change in intracellular signaling occurs as a result of cholesterol efflux, with the cholesterol acceptor methyl- β -cyclodextrin often invoking responses identical to HDL or apoA-I. The ABC transporters ABCA1 and ABCG1 and scavenger receptor class B, type I (SR-BI) frequently participate in the cellular responses. Structure-function relationships are emerging for signal initiation by ABCA1 and SR-BI, with plasma membrane cholesterol binding by the C-terminal transmembrane domain of SR-BI uniquely enabling it to serve as a sensor of changes in membrane cholesterol. Further investigation of the processes underlying HDL and apoA-I modulation of intracellular signaling will potentially reveal new prophylactic and therapeutic strategies to optimize both cardiovascular and metabolic health.

KW - Adenosine triphosphate-binding cassette (ABC) transporter A1 and G1

KW - Apolipoprotein A-I, PDZK1

KW - High density lipoprotein

KW - Scavenger receptor class B, type I

UR - http://www.scopus.com/inward/record.url?scp=84883198250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883198250&partnerID=8YFLogxK

U2 - 10.1194/jlr.R039479

DO - 10.1194/jlr.R039479

M3 - Article

VL - 54

SP - 2315

EP - 2324

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 9

ER -